“Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor”.BioEssays31(4): 422–34.(April 2009).doi:10.1002/bies.200800210.PMID19274663.
“The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling”.Cell40(4): 747–58.(April 1985).doi:10.1016/0092-8674(85)90334-4.PMID2859121.
“Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway”.Endocrinology153(5): 2152–63.(May 2012).doi:10.1210/en.2011-1843.PMID22355074.
“Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms”.The Biochemical Journal440(3): 397–403.(December 2011).doi:10.1042/BJ20110550.PMID21838706.
“Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor”.The Journal of Cell Biology217(5): 1643–1649.(May 2018).doi:10.1083/jcb.201711047.PMID29453311.
“Insulin interactions with its receptors: experimental evidence for negative cooperativity”.Biochemical and Biophysical Research Communications55(1): 154–61.(November 1973).doi:10.1016/S0006-291X(73)80072-5.PMID4361269.
“Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection”.Cell Metabolism.(August 2018).doi:10.1016/j.cmet.2018.08.003.PMID30174303.
“The Insulin Receptor Plays a Critical Role in T Cell Function and Adaptive Immunity”.Journal of Immunology198(5): 1910–1920.(March 2017).doi:10.4049/jimmunol.1601011.PMID28115529.
“Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit”.Diabetes49(1): 13–9.(January 2000).doi:10.2337/diabetes.49.1.13.PMID10615944.
“Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family”.Oncogene19(25): 2895–903.(June 2000).doi:10.1038/sj.onc.1203616.PMID10871840.
“Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus”.The Journal of Biological Chemistry271(15): 8882–6.(April 1996).doi:10.1074/jbc.271.15.8882.PMID8621530.
“Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains”.The Journal of Biological Chemistry273(12): 6860–7.(March 1998).doi:10.1074/jbc.273.12.6860.PMID9506989.
“Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains”.The Journal of Biological Chemistry272(5): 2659–67.(January 1997).doi:10.1074/jbc.272.5.2659.PMID9006901.
“Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2”.Oncogene19(16): 2052–9.(April 2000).doi:10.1038/sj.onc.1203469.PMID10803466.
“Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action”.The Journal of Biological Chemistry277(2): 1531–7.(January 2002).doi:10.1074/jbc.M101521200.PMID11606564.
“Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786”.The Journal of Biological Chemistry271(11): 5980–3.(March 1996).doi:10.1074/jbc.271.11.5980.PMID8626379.
“Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation”.The Journal of Biological Chemistry272(15): 10035–40.(April 1997).doi:10.1074/jbc.272.15.10035.PMID9092546.
“Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle”.Molecular Endocrinology15(4): 565–74.(April 2001).doi:10.1210/mend.15.4.0612.PMID11266508.
“Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling”.Diabetes51(6): 1921–30.(June 2002).doi:10.2337/diabetes.51.6.1921.PMID12031982.
“Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro”.Biochemical and Biophysical Research Communications199(2): 780–5.(March 1994).doi:10.1006/bbrc.1994.1297.PMID8135823.
“Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction”.The Journal of Biological Chemistry270(49): 29189–93.(December 1995).doi:10.1074/jbc.270.49.29189.PMID7493946.
“Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain”.Mammalian Genome10(12): 1160–7.(December 1999).doi:10.1007/s003359901183.PMID10594240.
“Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations”.Methods in Enzymology200: 62–81.(1991).doi:10.1016/0076-6879(91)00127-I.PMID1956339.
“Differential regulation of signaling pathways for insulin and insulin-like growth factor I”.Acta Biochimica Polonica46(1): 51–60.(1999).PMID10453981.
“The functional significance of Shc in insulin signaling as a substrate of the insulin receptor”.Endocrine Journal47(4): 373–81.(August 2000).doi:10.1507/endocrj.47.373.PMID11075717.
“Insulin receptor--structural and functional characteristics”.Medical Science Monitor7(1): 169–77.(2001).PMID11208515.